More on CVRX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.83 |
|
|||
| Open | $2.83 | ||||
| 52 Wk High | $0.35 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $2.86 | ||||
| Day Low | $2.70 | ||||
| P/E | N/A | ||||
| EPS | $-0.01 | ||||
| Volume | 373,411 | ||||
- CVRx board responds to shareholder letter on valuation concerns
- CVRx Responds to Letter from Pointillist Family Office
- Form SCHEDULE 13D CVRx, Inc. Filed by: Chernett Jorey
- CVRx, Inc. Investors Who Suffered Losses Should Contact Block & Leviton LLP
- CVRx shareholder pushes board to pursue sale of the company
- CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
- Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer
- CVRx, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
- CVRx Inc (CVRX) PT Lowered to $5 at Cantor Fitzgerald on Q2 Update Pressures
- Form SCHEDULE 13G CVRx, Inc. Filed by: Chernett Jorey
Entities mentioned with CVRX
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Canaccord Genuity | View Related Stories »
- JPMorgan | View Related Stories »
- IPO | View Related Stories »
- Show More...
